Experimental Drug for Metachromatic Leukodystrophy Gets Rare Pediatric Disease Designation
According to a story from EPM Magazine, the pharmaceutical company Orchard Therapeutics received Rare Pediatric Disease Designation for its gene therapy drug candidate OTL-200. The therapy is in development for…